Global and United States Dry Eye Syndrome Drugs Market Report & Forecast 2022-2028
Table of Contents1 Study Coverage
1.1 Dry Eye Syndrome Drugs Revenue in Dry Eye Syndrome Drugs Business (2017-2022) & (US$ Million) Introduction
1.2 Global Dry Eye Syndrome Drugs Outlook 2017 VS 2022 VS 2028
1.2.1 Global Dry Eye Syndrome Drugs Market Size for the Year 2017-2028
1.2.2 Global Dry Eye Syndrome Drugs Market Size for the Year 2017-2028
1.3 Dry Eye Syndrome Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Dry Eye Syndrome Drugs in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Dry Eye Syndrome Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Dry Eye Syndrome Drugs Market Dynamics
1.4.1 Dry Eye Syndrome Drugs Industry Trends
1.4.2 Dry Eye Syndrome Drugs Market Drivers
1.4.3 Dry Eye Syndrome Drugs Market Challenges
1.4.4 Dry Eye Syndrome Drugs Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Dry Eye Syndrome Drugs by Type
2.1 Dry Eye Syndrome Drugs Market Segment by Type
2.1.1 Antibiotic Drops
2.1.2 Hormone Drops
2.1.3 Artificial Tears
2.2 Global Dry Eye Syndrome Drugs Market Size by Type (2017, 2022 & 2028)
2.3 Global Dry Eye Syndrome Drugs Market Size by Type (2017-2028)
2.4 United States Dry Eye Syndrome Drugs Market Size by Type (2017, 2022 & 2028)
2.5 United States Dry Eye Syndrome Drugs Market Size by Type (2017-2028)
3 Dry Eye Syndrome Drugs by Application
3.1 Dry Eye Syndrome Drugs Market Segment by Application
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Household Use
3.2 Global Dry Eye Syndrome Drugs Market Size by Application (2017, 2022 & 2028)
3.3 Global Dry Eye Syndrome Drugs Market Size by Application (2017-2028)
3.4 United States Dry Eye Syndrome Drugs Market Size by Application (2017, 2022 & 2028)
3.5 United States Dry Eye Syndrome Drugs Market Size by Application (2017-2028)
4 Global Dry Eye Syndrome Drugs Competitor Landscape by Company
4.1 Global Dry Eye Syndrome Drugs Market Size by Company
4.1.1 Top Global Dry Eye Syndrome Drugs Companies Ranked by Revenue (2021)
4.1.2 Global Dry Eye Syndrome Drugs Revenue by Player (2017-2022)
4.2 Global Dry Eye Syndrome Drugs Concentration Ratio (CR)
4.2.1 Dry Eye Syndrome Drugs Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Dry Eye Syndrome Drugs in 2021
4.2.3 Global Dry Eye Syndrome Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Dry Eye Syndrome Drugs Headquarters, Revenue in Dry Eye Syndrome Drugs Business (2017-2022) & (US$ Million) Type
4.3.1 Global Dry Eye Syndrome Drugs Headquarters and Area Served
4.3.2 Global Dry Eye Syndrome Drugs Companies Revenue in Dry Eye Syndrome Drugs Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Dry Eye Syndrome Drugs Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Dry Eye Syndrome Drugs Market Size by Company
4.5.1 Top Dry Eye Syndrome Drugs Players in United States, Ranked by Revenue (2021)
4.5.2 United States Dry Eye Syndrome Drugs Revenue by Players (2020, 2021 & 2022)
5 Global Dry Eye Syndrome Drugs Market Size by Region
5.1 Global Dry Eye Syndrome Drugs Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Dry Eye Syndrome Drugs Market Size by Region (2017-2028)
5.2.1 Global Dry Eye Syndrome Drugs Market Size by Region: 2017-2022
5.2.2 Global Dry Eye Syndrome Drugs Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Dry Eye Syndrome Drugs Market Size YoY Growth 2017-2028
6.1.2 North America Dry Eye Syndrome Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Dry Eye Syndrome Drugs Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Dry Eye Syndrome Drugs Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 China Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.3 Europe
6.3.1 Europe Dry Eye Syndrome Drugs Market Size YoY Growth 2017-2028
6.3.2 Europe Dry Eye Syndrome Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Dry Eye Syndrome Drugs Market Size YoY Growth 2017-2028
6.4.2 Latin America Dry Eye Syndrome Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Dry Eye Syndrome Drugs Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Dry Eye Syndrome Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Allergan
7.1.1 Allergan Company Details
7.1.2 Allergan Business Overview
7.1.3 Allergan Dry Eye Syndrome Drugs Introduction
7.1.4 Allergan Revenue in Dry Eye Syndrome Drugs Business (2017-2022)
7.1.5 Allergan Recent Development
7.2 Novartis
7.2.1 Novartis Company Details
7.2.2 Novartis Business Overview
7.2.3 Novartis Dry Eye Syndrome Drugs Introduction
7.2.4 Novartis Revenue in Dry Eye Syndrome Drugs Business (2017-2022)
7.2.5 Novartis Recent Development
7.3 Santen
7.3.1 Santen Company Details
7.3.2 Santen Business Overview
7.3.3 Santen Dry Eye Syndrome Drugs Introduction
7.3.4 Santen Revenue in Dry Eye Syndrome Drugs Business (2017-2022)
7.3.5 Santen Recent Development
7.4 Takeda
7.4.1 Takeda Company Details
7.4.2 Takeda Business Overview
7.4.3 Takeda Dry Eye Syndrome Drugs Introduction
7.4.4 Takeda Revenue in Dry Eye Syndrome Drugs Business (2017-2022)
7.4.5 Takeda Recent Development
7.5 Otsuka
7.5.1 Otsuka Company Details
7.5.2 Otsuka Business Overview
7.5.3 Otsuka Dry Eye Syndrome Drugs Introduction
7.5.4 Otsuka Revenue in Dry Eye Syndrome Drugs Business (2017-2022)
7.5.5 Otsuka Recent Development
7.6 Eyegate Pharma
7.6.1 Eyegate Pharma Company Details
7.6.2 Eyegate Pharma Business Overview
7.6.3 Eyegate Pharma Dry Eye Syndrome Drugs Introduction
7.6.4 Eyegate Pharma Revenue in Dry Eye Syndrome Drugs Business (2017-2022)
7.6.5 Eyegate Pharma Recent Development
7.7 Can-Fite BioPharma
7.7.1 Can-Fite BioPharma Company Details
7.7.2 Can-Fite BioPharma Business Overview
7.7.3 Can-Fite BioPharma Dry Eye Syndrome Drugs Introduction
7.7.4 Can-Fite BioPharma Revenue in Dry Eye Syndrome Drugs Business (2017-2022)
7.7.5 Can-Fite BioPharma Recent Development
7.8 Bausch and Lomb
7.8.1 Bausch and Lomb Company Details
7.8.2 Bausch and Lomb Business Overview
7.8.3 Bausch and Lomb Dry Eye Syndrome Drugs Introduction
7.8.4 Bausch and Lomb Revenue in Dry Eye Syndrome Drugs Business (2017-2022)
7.8.5 Bausch and Lomb Recent Development
7.9 Auven Therapeutics (Celtic)
7.9.1 Auven Therapeutics (Celtic) Company Details
7.9.2 Auven Therapeutics (Celtic) Business Overview
7.9.3 Auven Therapeutics (Celtic) Dry Eye Syndrome Drugs Introduction
7.9.4 Auven Therapeutics (Celtic) Revenue in Dry Eye Syndrome Drugs Business (2017-2022)
7.9.5 Auven Therapeutics (Celtic) Recent Development
7.10 Bridge Pharma
7.10.1 Bridge Pharma Company Details
7.10.2 Bridge Pharma Business Overview
7.10.3 Bridge Pharma Dry Eye Syndrome Drugs Introduction
7.10.4 Bridge Pharma Revenue in Dry Eye Syndrome Drugs Business (2017-2022)
7.10.5 Bridge Pharma Recent Development
7.11 Cellzome
7.11.1 Cellzome Company Details
7.11.2 Cellzome Business Overview
7.11.3 Cellzome Dry Eye Syndrome Drugs Introduction
7.11.4 Cellzome Revenue in Dry Eye Syndrome Drugs Business (2017-2022)
7.11.5 Cellzome Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer
List of TablesTable 1. Dry Eye Syndrome Drugs Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
Table 2. Dry Eye Syndrome Drugs Market Trends
Table 3. Dry Eye Syndrome Drugs Market Drivers
Table 4. Dry Eye Syndrome Drugs Market Challenges
Table 5. Dry Eye Syndrome Drugs Market Restraints
Table 6. Global Dry Eye Syndrome Drugs Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Dry Eye Syndrome Drugs Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Dry Eye Syndrome Drugs Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Dry Eye Syndrome Drugs Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Dry Eye Syndrome Drugs Companies in Global Market, Ranking by Revenue (2021)
Table 11. Global Dry Eye Syndrome Drugs Revenue by Player, (US$ Million), 2017-2022
Table 12. Global Dry Eye Syndrome Drugs Revenue Share by Player, 2017-2022
Table 13. Global Dry Eye Syndrome Drugs Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Dry Eye Syndrome Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dry Eye Syndrome Drugs as of 2021)
Table 15. Top Players of Dry Eye Syndrome Drugs in Global Market, Headquarters and Area Served
Table 16. Companies Revenue in Dry Eye Syndrome Drugs Business (2017-2022) & (US$ Million) Type
Table 17. Date of International Companies Enter into Dry Eye Syndrome Drugs Market
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Top Dry Eye Syndrome Drugs Players in United States Market, Ranking by Revenue (2021)
Table 20. United States Dry Eye Syndrome Drugs Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 21. United States Dry Eye Syndrome Drugs Revenue Share by Players, 2020, 2021 & 2022
Table 22. Global Dry Eye Syndrome Drugs Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 23. Global Dry Eye Syndrome Drugs Market Size by Region (2017-2022) & (US$ Million)
Table 24. Global Dry Eye Syndrome Drugs Market Size Forecast by Region (2023-2028) & (US$ Million)
Table 25. North America Dry Eye Syndrome Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 26. Asia Pacific Dry Eye Syndrome Drugs Sales in Value by Region (2017-2028) & (US$ Million)
Table 27. Europe Dry Eye Syndrome Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 28. Latin Americaa Dry Eye Syndrome Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 29. Middle East and Africa Dry Eye Syndrome Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 30. Allergan Company Details
Table 31. Allergan Business Overview
Table 32. Allergan Dry Eye Syndrome Drugs Product
Table 33. Allergan Revenue in Dry Eye Syndrome Drugs Business (2017-2022) & (US$ Million)
Table 34. Allergan Recent Development
Table 35. Novartis Company Details
Table 36. Novartis Business Overview
Table 37. Novartis Dry Eye Syndrome Drugs Product
Table 38. Novartis Revenue in Dry Eye Syndrome Drugs Business (2017-2022) & (US$ Million)
Table 39. Novartis Recent Development
Table 40. Santen Company Details
Table 41. Santen Business Overview
Table 42. Santen Dry Eye Syndrome Drugs Product
Table 43. Santen Revenue in Dry Eye Syndrome Drugs Business (2017-2022) & (US$ Million)
Table 44. Santen Recent Development
Table 45. Takeda Company Details
Table 46. Takeda Business Overview
Table 47. Takeda Dry Eye Syndrome Drugs Product
Table 48. Takeda Revenue in Dry Eye Syndrome Drugs Business (2017-2022) & (US$ Million)
Table 49. Takeda Recent Development
Table 50. Otsuka Company Details
Table 51. Otsuka Business Overview
Table 52. Otsuka Dry Eye Syndrome Drugs Product
Table 53. Otsuka Revenue in Dry Eye Syndrome Drugs Business (2017-2022) & (US$ Million)
Table 54. Otsuka Recent Development
Table 55. Eyegate Pharma Company Details
Table 56. Eyegate Pharma Business Overview
Table 57. Eyegate Pharma Dry Eye Syndrome Drugs Product
Table 58. Eyegate Pharma Revenue in Dry Eye Syndrome Drugs Business (2017-2022) & (US$ Million)
Table 59. Eyegate Pharma Recent Development
Table 60. Can-Fite BioPharma Company Details
Table 61. Can-Fite BioPharma Business Overview
Table 62. Can-Fite BioPharma Dry Eye Syndrome Drugs Product
Table 63. Can-Fite BioPharma Revenue in Dry Eye Syndrome Drugs Business (2017-2022) & (US$ Million)
Table 64. Can-Fite BioPharma Recent Development
Table 65. Bausch and Lomb Company Details
Table 66. Bausch and Lomb Business Overview
Table 67. Bausch and Lomb Dry Eye Syndrome Drugs Product
Table 68. Bausch and Lomb Revenue in Dry Eye Syndrome Drugs Business (2017-2022) & (US$ Million)
Table 69. Bausch and Lomb Recent Development
Table 70. Auven Therapeutics (Celtic) Company Details
Table 71. Auven Therapeutics (Celtic) Business Overview
Table 72. Auven Therapeutics (Celtic) Dry Eye Syndrome Drugs Product
Table 73. Auven Therapeutics (Celtic) Revenue in Dry Eye Syndrome Drugs Business (2017-2022) & (US$ Million)
Table 74. Auven Therapeutics (Celtic) Recent Development
Table 75. Bridge Pharma Company Details
Table 76. Bridge Pharma Business Overview
Table 77. Bridge Pharma Dry Eye Syndrome Drugs Product
Table 78. Bridge Pharma Revenue in Dry Eye Syndrome Drugs Business (2017-2022) & (US$ Million)
Table 79. Bridge Pharma Recent Development
Table 80. Cellzome Company Details
Table 81. Cellzome Business Overview
Table 82. Cellzome Dry Eye Syndrome Drugs Product
Table 83. Cellzome Revenue in Dry Eye Syndrome Drugs Business (2017-2022) & (US$ Million)
Table 84. Cellzome Recent Development
Table 85. Research Programs/Design for This Report
Table 86. Key Data Information from Secondary Sources
Table 87. Key Data Information from Primary Sources
List of FiguresFigure 1. Dry Eye Syndrome Drugs Product Picture
Figure 2. Global Dry Eye Syndrome Drugs Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Dry Eye Syndrome Drugs Market Size 2017-2028 (US$ Million)
Figure 4. United States Dry Eye Syndrome Drugs Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 5. United States Dry Eye Syndrome Drugs Market Size 2017-2028 (US$ Million)
Figure 6. United States Dry Eye Syndrome Drugs Market Share in Global 2017-2028
Figure 7. Dry Eye Syndrome Drugs Report Years Considered
Figure 8. Product Picture of Antibiotic Drops
Figure 9. Product Picture of Hormone Drops
Figure 10. Product Picture of Artificial Tears
Figure 11. Global Dry Eye Syndrome Drugs Market Share by Type in 2022 & 2028
Figure 12. Global Dry Eye Syndrome Drugs Market Size by Type (2017-2028) & (US$ Million)
Figure 13. Global Dry Eye Syndrome Drugs Market Share by Type (2017-2028)
Figure 14. United States Dry Eye Syndrome Drugs Market Share by Type in 2022 & 2028
Figure 15. United States Dry Eye Syndrome Drugs Market Size by Type (2017-2028) & (US$ Million)
Figure 16. United States Dry Eye Syndrome Drugs Market Share by Type (2017-2028)
Figure 17. Product Picture of Hospitals
Figure 18. Product Picture of Clinics
Figure 19. Product Picture of Household Use
Figure 20. Global Dry Eye Syndrome Drugs Market Share by Application in 2022 & 2028
Figure 21. Global Dry Eye Syndrome Drugs Market Size by Application (2017-2028) & (US$ Million)
Figure 22. Global Dry Eye Syndrome Drugs Market Share by Application (2017-2028)
Figure 23. United States Dry Eye Syndrome Drugs Market Share by Application in 2022 & 2028
Figure 24. United States Dry Eye Syndrome Drugs Market Size by Application (2017-2028) & (US$ Million)
Figure 25. United States Dry Eye Syndrome Drugs Market Share by Application (2017-2028)
Figure 26. North America Dry Eye Syndrome Drugs Market Size Growth Rate 2017-2028 (US$ Million)
Figure 27. U.S. Dry Eye Syndrome Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 28. Canada Dry Eye Syndrome Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 29. Europe Dry Eye Syndrome Drugs Market Size Growth Rate 2017-2028 (US$ Million)
Figure 30. Germany Dry Eye Syndrome Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 31. France Dry Eye Syndrome Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 32. U.K. Dry Eye Syndrome Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 33. Italy Dry Eye Syndrome Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 34. Russia Dry Eye Syndrome Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 35. Asia-Pacific Dry Eye Syndrome Drugs Market Size Growth Rate 2017-2028 (US$ Million)
Figure 36. China Dry Eye Syndrome Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 37. Japan Dry Eye Syndrome Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 38. South Korea Dry Eye Syndrome Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 39. India Dry Eye Syndrome Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 40. Australia Dry Eye Syndrome Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 41. China Taiwan Dry Eye Syndrome Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 42. Indonesia Dry Eye Syndrome Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 43. Thailand Dry Eye Syndrome Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 44. Malaysia Dry Eye Syndrome Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 45. Latin America Dry Eye Syndrome Drugs Market Size Growth Rate 2017-2028 (US$ Million)
Figure 46. Mexico Dry Eye Syndrome Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 47. Brazil Dry Eye Syndrome Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 48. Argentina Dry Eye Syndrome Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 49. Middle East & Africa Dry Eye Syndrome Drugs Market Size Growth Rate 2017-2028 (US$ Million)
Figure 50. Turkey Dry Eye Syndrome Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 51. Saudi Arabia Dry Eye Syndrome Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 52. UAE Dry Eye Syndrome Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 53. Allergan Revenue Growth Rate in Dry Eye Syndrome Drugs Business (2017-2022)
Figure 54. Novartis Revenue Growth Rate in Dry Eye Syndrome Drugs Business (2017-2022)
Figure 55. Santen Revenue Growth Rate in Dry Eye Syndrome Drugs Business (2017-2022)
Figure 56. Takeda Revenue Growth Rate in Dry Eye Syndrome Drugs Business (2017-2022)
Figure 57. Otsuka Revenue Growth Rate in Dry Eye Syndrome Drugs Business (2017-2022)
Figure 58. Eyegate Pharma Revenue Growth Rate in Dry Eye Syndrome Drugs Business (2017-2022)
Figure 59. Can-Fite BioPharma Revenue Growth Rate in Dry Eye Syndrome Drugs Business (2017-2022)
Figure 60. Bausch and Lomb Revenue Growth Rate in Dry Eye Syndrome Drugs Business (2017-2022)
Figure 61. Auven Therapeutics (Celtic) Revenue Growth Rate in Dry Eye Syndrome Drugs Business (2017-2022)
Figure 62. Bridge Pharma Revenue Growth Rate in Dry Eye Syndrome Drugs Business (2017-2022)
Figure 63. Cellzome Revenue Growth Rate in Dry Eye Syndrome Drugs Business (2017-2022)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed